AR092356A1 - Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion - Google Patents

Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion

Info

Publication number
AR092356A1
AR092356A1 ARP130102609A ARP130102609A AR092356A1 AR 092356 A1 AR092356 A1 AR 092356A1 AR P130102609 A ARP130102609 A AR P130102609A AR P130102609 A ARP130102609 A AR P130102609A AR 092356 A1 AR092356 A1 AR 092356A1
Authority
AR
Argentina
Prior art keywords
formulation
rosuvastatin
oral administration
preparation
coating layer
Prior art date
Application number
ARP130102609A
Other languages
English (en)
Inventor
Hyun Park Jae
Soo Woo Jong
Cheul Kim Jin
Woo Jeong Ki
Ho Kim Jae
Il Kim Yong
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of AR092356A1 publication Critical patent/AR092356A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Reivindicación 1: Una formulación compuesta para administración oral, que comprende: 1) un núcleo de liberación prolongada que comprende metformina o una de sus sales aceptables desde el punto de vista farmacéutico, y un agente de control de liberación; 2) una primera capa de recubrimiento formada sobre una superficie del núcleo, que comprende un material de recubrimiento funcional; y 3) una segunda capa de recubrimiento formada sobre una superficie de la primera capa de recubrimiento, que comprende rosuvastatina o una de sus sales aceptables desde el punto de vista farmacéutico y un agente de alcalinización.
ARP130102609A 2012-07-24 2013-07-23 Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion AR092356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120080347A KR20140013436A (ko) 2012-07-24 2012-07-24 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제

Publications (1)

Publication Number Publication Date
AR092356A1 true AR092356A1 (es) 2015-04-15

Family

ID=49223464

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102609A AR092356A1 (es) 2012-07-24 2013-07-23 Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion

Country Status (5)

Country Link
KR (1) KR20140013436A (es)
AR (1) AR092356A1 (es)
TW (1) TWI573587B (es)
UY (1) UY34931A (es)
WO (1) WO2014017833A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY181172A (en) * 2014-06-30 2020-12-21 Hanmi Pharm Ind Co Ltd Composite preparation comprising active ingredient-containing film coating layer
BR112016030731A2 (pt) * 2014-06-30 2017-08-22 Hanmi Pharm Ind Co Ltd Preparação de compósito, e, método de preparação de uma preparação de compósito
CN106659690B (zh) * 2014-06-30 2020-08-18 韩美药品株式会社 包括含有活性成分的膜包衣层的复合制剂
CN104523650B (zh) * 2014-12-20 2017-04-12 山东新时代药业有限公司 一种含有瑞舒伐他汀钙的胶囊
KR101526825B1 (ko) * 2014-12-23 2015-06-08 주식회사 한독 당뇨병 치료용 약제학적 조성물
BR112019009709A2 (pt) * 2016-11-15 2019-08-13 Lg Chemical Ltd preparação de combinação.
KR102687535B1 (ko) * 2018-07-06 2024-07-24 한미약품 주식회사 무정형의 다파글리플로진 l-프롤린을 포함하는 약학적 제제 및 이의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
EP1510208A1 (en) * 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
KR101752014B1 (ko) * 2009-05-01 2017-06-28 아데어 파마슈티컬스 인코포레이티드 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물
JP5827952B2 (ja) * 2009-10-09 2015-12-02 ユンジン・ファーム・カンパニー・リミテッドＹｕｎｇｊｉｎ Ｐｈａｒｍ． Ｃｏ． Ｌｔｄ． 速効性と持続性を同時に有する薬剤学的組成物
US9005636B2 (en) * 2009-12-30 2015-04-14 Bcworld Pharm Co., Ltd. Pharmaceutical composition comprising metformin and rosuvastatin

Also Published As

Publication number Publication date
KR20140013436A (ko) 2014-02-05
TWI573587B (zh) 2017-03-11
WO2014017833A1 (en) 2014-01-30
UY34931A (es) 2013-09-02
TW201408283A (zh) 2014-03-01

Similar Documents

Publication Publication Date Title
AR092356A1 (es) Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
RS54238B1 (en) ORAL FILM FORMULATIONS CONTAINING DAPOXETINE AND TADALAFIL
DOP2017000306A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
AR088232A1 (es) Composiciones farmaceuticas
CO2020000490A2 (es) Preparación que comprende vonoprazán
DOP2016000024A (es) Comprimido farmacéutico que comprende ácido acetilsalicílico y clopidogrel
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
AR098417A1 (es) Formulación farmacéutica combinada que comprende amlodipina, losartán y rosuvastatina
AR104257A1 (es) Tableta de ribociclib
CO2017006898A2 (es) Formulación de relación fija de insulina glargina/lixisenatida
CL2018001590A1 (es) Composiciones farmacéuticas que comprenden algun derivado de fenilaminopirimidina.
CL2012003341A1 (es) Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
PE20150721A1 (es) Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion
AR108233A1 (es) Composiciones farmacéuticas orales de nicotinamida
DOP2015000089A (es) Composición de difenidol de liberación prolongada
AR097202A1 (es) Composiciones farmacéuticas de ranolazina y dronedarona, procedimiento para elaborar tableta bicapa
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
DOP2013000024A (es) Composicion farmaceutica de liberacion prolongada de trimetazidina
CO2018002046A2 (es) Nueva composición oral de libreación retardada dual de dexlansoprazol
EP3873441A4 (en) A new use of the poloxamer as a pharmacologically active substance
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
RS53033B (en) VILDAGLIPTIN AND GLIMEPIRID COMBINATIONS
DOP2021000052A (es) Procedimiento para la preparación de una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina

Legal Events

Date Code Title Description
FB Suspension of granting procedure